Once enrolled in the program and evaluated by our board-certified provider, the medication and the supplies will be discreetly shipped to your home or office
Tirzepatide, a dual GLP-1 and GIP receptor agonist, has demonstrated superior efficacy for weight reduction and improved metabolic health compared with single GLP-1 agonists
In 2021, the FDA stamped its approval on high-dose semaglutide under the brand name Wegovy, officially giving doctors a new heavyweight contender for chronic weight management
Clinicians at Found decide dosing schedules based on the unique traits of a patients biology and medical history. Those with a medical contraindication or those who need a full dosage to be effective may be advised against microdosing
Semaglutide has ramp-up periods, during which the last thing you need are more intense symptoms
In the meantime, a burgeoning startup ecosystem is structuring, and it is already giving us a glimpse of what we may see in the future